
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $130.8M | -- | -- | $0.38 | -- |
07/29/2025 | Q2 | $125.9M | -- | -- | $0.35 | -- |
04/29/2025 | Q1 | $117.6M | $118M | $0.32 | $0.32 | -$0.00 |
01/28/2025 | Q4 | $119.9M | $120.4M | $0.35 | $0.35 | -$0.00 |
10/29/2024 | Q3 | $119.5M | $121.2M | $0.31 | $0.36 | -$0.05 |
07/23/2024 | Q2 | $118M | $120.1M | $0.36 | $0.35 | $0.01 |
04/23/2024 | Q1 | $120M | $116.3M | $0.37 | $0.36 | $0.01 |
01/30/2024 | Q4 | $123.7M | $120M | $0.44 | $0.39 | $0.05 |
10/24/2023 | Q3 | $124M | $122.6M | $0.38 | $0.40 | -$0.02 |
07/25/2023 | Q2 | $122.1M | $122.3M | $0.42 | $0.41 | $0.01 |
04/25/2023 | Q1 | -- | $117.3M | $0.30 | -- | -- |
01/24/2023 | Q4 | -- | $112.3M | $0.38 | -- | -- |
10/25/2022 | Q3 | -- | $108.3M | $0.36 | -- | -- |
07/26/2022 | Q2 | -- | $98.2M | $0.33 | -- | -- |
04/27/2022 | Q1 | -- | $92.1M | $0.29 | -- | -- |
01/25/2022 | Q4 | -- | $96.3M | $0.37 | -- | -- |
10/26/2021 | Q3 | -- | $97.9M | $0.36 | -- | -- |
07/27/2021 | Q2 | -- | $94.3M | $0.31 | -- | -- |
04/27/2021 | Q1 | -- | $96.8M | $0.41 | -- | -- |
01/26/2021 | Q4 | -- | $94.1M | $0.27 | -- | -- |
10/27/2020 | Q3 | -- | $93.1M | $0.20 | -- | -- |
07/28/2020 | Q2 | -- | $88.5M | $0.24 | -- | -- |
04/28/2020 | Q1 | -- | $87M | $0.05 | -- | -- |
01/28/2020 | Q4 | -- | $91.3M | $0.27 | -- | -- |
10/29/2019 | Q3 | -- | $90.6M | $0.27 | -- | -- |
07/23/2019 | Q2 | -- | $89M | $0.28 | -- | -- |
04/23/2019 | Q1 | -- | $84.4M | $0.25 | -- | -- |
01/29/2019 | Q4 | -- | $85.6M | $0.27 | -- | -- |
10/23/2018 | Q3 | -- | $83.6M | $0.25 | -- | -- |
07/24/2018 | Q2 | -- | $90M | $0.32 | -- | -- |
04/24/2018 | Q1 | -- | $81.7M | $0.24 | -- | -- |
01/23/2018 | Q4 | -- | $84.3M | $0.04 | -- | -- |
10/25/2017 | Q3 | -- | $79.4M | $0.22 | -- | -- |
07/26/2017 | Q2 | -- | $76.7M | $0.14 | -- | -- |
04/25/2017 | Q1 | -- | $68.8M | $0.18 | -- | -- |
01/25/2017 | Q4 | -- | $69.9M | $0.20 | -- | -- |
10/26/2016 | Q3 | -- | $66.6M | $0.19 | -- | -- |
07/27/2016 | Q2 | -- | $64.6M | $0.14 | -- | -- |
04/26/2016 | Q1 | -- | $62.5M | $0.14 | -- | -- |
01/27/2016 | Q4 | -- | $63.5M | $0.11 | -- | -- |
10/28/2015 | Q3 | -- | $62.2M | $0.14 | -- | -- |
First Commonwealth Financial reported $118M worth of top line sales in its most recent quarter.
First Commonwealth Financial announced earnings per share of $0.32 which represents a miss of analyst forecast a $0.32 per share.
First Commonwealth Financial reported -- that represents -- per share over the last quarter.
First Commonwealth Financial's earnings are forecast to grow from $1.39 per share to $1.40 per share next year representing an increase of 3.39%.
First Commonwealth Financial's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.